Pioneer Valley Life Sciences Institute, University of Massachusetts, Springfield, Massachusetts, United States of America.
PLoS One. 2011;6(10):e25819. doi: 10.1371/journal.pone.0025819. Epub 2011 Oct 3.
We previously reported that a secreted glycoprotein YKL-40 acts as an angiogenic factor to promote breast cancer angiogenesis. However, its functional role in normal mammary gland development is poorly understood. Here we investigated its biophysiological activity in mammary epithelial development and mammary tissue morphogenesis. YKL-40 was expressed exclusively by ductal epithelial cells of parous and non-parous mammary tissue, but was dramatically up-regulated at the beginning of involution. To mimic ductal development and explore activity of elevated YKL-40 during mammary tissue regression in vivo, we grew a mammary epithelial cell line 76N MECs in a 3-D Matrigel system in the presence of lactogenic hormones including prolactin, hydrocortisone, and insulin. Treatment of 76N MECs with recombinant YKL-40 significantly inhibited acinar formation, luminal polarization, and secretion. YKL-40 also suppressed expression of E-cadherin but increased MMP-9 and cell motility, the crucial mechanisms that mediate mammary tissue remodeling during involution. In addition, engineering of 76N MECs with YKL-40 gene to express ectopic YKL-40 recapitulated the same activities as recombinant YKL-40 in the inhibition of cell differentiation. These results suggest that YKL-40-mediated inhibition of cell differentiation and polarization in the presence of lactogenic hormones may represent its important function during mammary tissue involution. Identification of this biophysiological property will enhance our understanding of its pathologic role in the later stage of breast cancer that is developed from poorly differentiated and highly invasive cells.
我们之前曾报道,一种分泌型糖蛋白 YKL-40 作为一种血管生成因子,促进乳腺癌血管生成。然而,其在正常乳腺发育中的功能作用尚不清楚。在这里,我们研究了它在乳腺上皮细胞发育和乳腺组织形态发生中的生物物理活性。YKL-40 仅由产仔和非产仔乳腺组织的导管上皮细胞表达,但在退化开始时显著上调。为了模拟导管发育并探索体内乳腺组织退化过程中升高的 YKL-40 的活性,我们在含有催乳素、氢化可的松和胰岛素等泌乳激素的 3-D Matrigel 系统中培养了乳腺上皮细胞系 76N MECs。用重组 YKL-40 处理 76N MECs 可显著抑制小泡形成、腔极化和分泌。YKL-40 还抑制了 E-钙粘蛋白的表达,但增加了 MMP-9 和细胞迁移,这是介导退化过程中乳腺组织重塑的关键机制。此外,通过 YKL-40 基因工程使 76N MECs 表达异位 YKL-40,可重现重组 YKL-40 抑制细胞分化的相同活性。这些结果表明,在泌乳激素存在的情况下,YKL-40 介导的细胞分化和极化抑制可能代表其在乳腺组织退化过程中的重要功能。对这种生物物理特性的识别将增强我们对其在乳腺癌晚期的病理作用的理解,乳腺癌是由分化不良和高度侵袭性细胞发展而来的。